Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD)

Last updated: October 30, 2023
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Overall Status: Active - Recruiting

Phase

N/A

Condition

Severe Short Stature

Retinitis Pigmentosa

Ichthyosis

Treatment

N/A

Clinical Study ID

NCT01668186
11-090-PED
  • All Genders

Study Summary

The Peroxisome Biogenesis Disorders (PBD) are a group of inherited disorders due to defects in peroxisome assembly causing complex developmental and metabolic sequelae. In spite of advancements in peroxisome biology, the pathophysiology remains unknown, the spectrum of phenotypes poorly characterized and the natural history not yet systematically reported. Our aims are to further define this population clinically, biochemically and genetically. The investigators will prospectively follow patients from Canada, the US and internationally, and collect data from medical evaluations, blood, urine and imaging studies that would be performed on a clinical care basis. For patients who are unable to attend our clinic, we will collect all medical records and images since birth as well as subsequent records/images for the next 5 years or until the end of the study. Clinical data from medical records will be banked in our Peroxisomal Disorder Research Databank and Biobank. The investigators will use this information to identify standards of care and improve management.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of PBD or
  • Single peroxisome enzyme/protein defect with phenotype similar to PBD

Exclusion

Exclusion Criteria:

  • Not a PBD
  • Not a single peroxisome enzyme/protein defect with phenotype similar to PBD

Study Design

Total Participants: 244
Study Start date:
January 01, 2012
Estimated Completion Date:
January 31, 2025

Study Description

Participants have the option to be seen in consultation at the McGill University Health Centre in Montreal, Canada, on a yearly basis. This includes a consultation in Genetics, Nutrition, Neurology, and Ophthalmology (OCT and FAF exams). All medical records and images will be collected, retrospectively and prospectively, until the end of the study, and entered anonymously in a database. Biospecimens will be collected to identify new biomarkers. Candidate drugs will be evaluated for recovery of peroxisome functions in cultured fibroblasts.

Connect with a study center

  • Research Institute of the McGill University Health Center

    Montreal, Quebec H4A 3J1
    Canada

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.